Hyun Taek Kim

6430445, Aug 6, 2002

Nov 13, 2000

09/710652

Hyun Jong Kim - Los Angeles CA, 90010
Ki Suk Kim - Los Angeles CA, 90010

A61F 200

607100, 607 2, 600 13

An anti-aging device to control the level of oxidation occurring at skin surface is described. The device is plugged into an electrical outlet to allow electromagnetic waves to pass through the inner surface, which has been pre-treated with far infrared light. The resulting affect on the skin is the reduced appearance of wrinkles and other signs of aging.

D490875, Jun 1, 2004

Dec 3, 2002

29/171904

Hyun Jong Kim - Los Angeles CA, 90010

2301

D23207, D7378

6768014, Jul 27, 2004

Jun 27, 2002

10/169139

Hyun Koo Kim - Bethesda MD
Pemmaraju N. Rao - San Antonio TX
James W. Cessac - San Antonio TX
Anne Marie Simmons - San Antonio TX

The United States of America as represented by the Department of Health and Human Services - Washington DC

C07J 500

552595

A compound having general formula (I) in which R is a member selected from the group consisting of âOCH , âSCH , âN(CH ) , âNHCH , âCHO, âCOCH and âCHOHCH ; R is a member selected from the group consisting of halogen, alkyl, acyl, hydroxy, alkoxy, acyloxy, alkyl carbonate, cypionyloxy, S-alkyl and S-acyl; R is a member selected from the group consisting of alkyl, hydroxy, alkoxy and acyloxy; R is a member selected from the group consisting of hydrogen and alkyl; and X is a member selected from the group consisting of âO and âNâOR , wherein R is a member selected from the group consisting of hydrogen and alkyl. In addition to providing the compounds of formula (I), the present invention provides methods wherein the compounds of formula (I) are advantageously used, inter alia, to antagonize endogenous progesterone; to induce menses; to treat endometriosis; to treat dysmenorrhea; to treat endocrine hormone-dependent tumors; to treat uterine fibroids; to inhibit uterine endometrial proliferation; to induce labor; and for contraception.

6783664, Aug 31, 2004

Nov 27, 2002

10/307049

Hyun Jong Kim - Los Angeles CA, 90010

C02F 148

210 85, 210 94, 210222, 210223, 366142

A water-treating device having a water jar, a magnetic agitator, an additive container having a bottom plate and a sleeve attached to the bottom plate, and an agitator driver that rotates the magnetic driver. The sleeve of the additive container has an outer wall, an inner wall, and mineral particles filled between the inner wall and the outer wall. The magnetic agitator has a base and a Y-shaped fin that protrudes upward from the base. The magnetic agitator has a magnetic bar between the fin and the base. The base has a shape of a disc having an upper surface and a lower surface, wherein the lower surface is convex. A metal plate is attached to the lower surface. The bottom plate also has a metal plate that contacts the metal plate of the base.

6861415, Mar 1, 2005

Apr 30, 1997

09/180132

Hyun K. Kim - Bethesda MD, US
Richard P. Blye - Highland MD, US
Pemmaraju N. Rao - San Antonio TX, US
James W. Cessac - San Antonio TX, US
Carmie K. Acosta - San Antonio TX, US

The United States of America as represented by the Department of Health and Human Services - Washington DC

A61K031/56
C07J005/00
C07J009/00

514179, 514182, 514841, 552556, 552595, 552598, 552602, 552608

A compound having the general formula: in which: Ris a member selected from the group consisting of —OCH, —SCH, —N(CH), —NHCH, —CHO, —COCHand —CHOHCH; Ris a member selected from the group consisting of halogen, alkyl, acyl, hydroxy, alkoxy, acyloxy, alkyl carbonate, cypionyloxy, S-alkyl and S-acyl; Ris a member selected from the group consisting of alkyl, hydroxy, alkoxy and acyloxy; Ris a member selected from the group consisting of hydrogen and alkyl; and X is a member selected from the group consisting of ═O and ═N—OR, wherein Ris a member selected from the group consisting of hydrogen and alkyl. In addition to providing the compounds of Formula I, the present invention provides methods wherein the compounds of Formula I are advantageously used, inter alia, to antagonize endogenous progesterone; to induce menses; to treat endometriosis; to treat dysmenorrhea; to treat endocrine hormone-dependent tumors; to treat uterine fibroids; to inhibit uterine endometrial proliferation; to induce labor; and for contraception.

6900193, May 31, 2005

Mar 17, 2000

09/526855

Hyun K. Kim - Bethesda MD, US
Richard P. Blye - Highland MD, US
Pemmaraju N. Rao - San Antonio TX, US
James W. Cessac - San Antonio TX, US
Carmie K. Acosta - San Antonio TX, US
Anne Marie Simmons - San Antonio TX, US

The United States of America as represented by the Department of Health and Human Services - Washington DC

A61K031/56
A61K031/58
C07J005/00
C07J009/00
C07J043/00

514179, 514176, 514177, 514182, 514841, 540107, 552556, 552595, 552598, 552602, 552608

The present invention relates, inter alia, to compounds having the general formula: in which: Ris a member selected from the group consisting of —OCH, —SCH, —N(CH), —NHCH, —NCH, —NCH, —NCHO, —CHO, —CH(OH)CH, —C(O)CH, —O(CH)N(CH), and —O(CH)NCH; Ris a member selected from the group consisting of hydrogen, halogen, alkyl, acyl, hydroxy, alkoxy (e. g. , methoxy, ethoxy, vinyloxy, ethynyloxy, cyclopropyloxy, etc. ), acyloxy (e. g. , acetoxy, glycinate, etc. ), alkylcarbonate, cypionyloxy, S-alkyl, —SCN, S-acyl and —OC(O)R, wherein Ris a functional group including, but not limited to, alkyl (e. g. , methyl, ethyl, etc. ), alkoxy ester (e. g. , —CHOCH) and alkoxy (—OCH); Ris a member selected from the group consisting of alkyl, hydroxy, alkoxy and acyloxy; Ris a member selected from the group consisting of hydrogen and alkyl; and X is a member selected from the group consisting of ═O and ═N—OR, wherein Ris a member selected from the group consisting of hydrogen and alkyl. In addition to providing the compounds of Formula I, the present invention provides methods wherein the compounds of Formula I are advantageously used, inter alia, to antagonize endogenous progesterone; to induce menses; to treat endometriosis; to treat dysmenorrhea; to treat endocrine hormone-dependent tumors; to treat meningiomas; to treat uterine leiomyomas; to treat uterine fibroids; to inhibit uterine endometrial proliferation; to induce cervical ripening; to induce labor; and for contraception.

6944991, Sep 20, 2005

Dec 29, 2003

10/745591

Hyun T. Kim - Springfield VA, US

E04D013/04
E04D013/064

52 11, 52 12, 52 14, 52 15, 248 481, 248 482

A rain gutter cover for covering the gutter, includes a large space screen a curved upper leg portion extended from a roof shingle for engaging with an upper end of the large space screen, and a plurality of supports attached to the curved front leg portion and to a lower leg portion whereby the rain gutter can keep out leaves and other debris, and allow water to enter thereinto and fall down into the gutter effectively and accurately.

7073277, Jul 11, 2006

Jun 25, 2004

10/877625

Robert Erb - Plandome NY, US
Hyun Jin Kim - Carlsbad CA, US
Marco Grott - San Marcos CA, US

Taylor Made Golf Company, Inc. - Carlsbad CA

A43B 13/38

36 43, 36154, 5253309, 5253325, 5253288, 524504, 524507, 528 44, 528 52, 528 85

The invention relates to the field of shoes in general, and more specifically to the application of microspheres in shoe material formulations to yield desired shoe properties. Even more specifically, the invention relates to a shoe component prepared from a closed cell foam incorporating microspheres to yield controlled cell size, cell size distribution and expansion characteristics. In another embodiment, the invention also relates to an inner sole for a shoe prepared from the reaction product of a polymer matrix component and a curing agent where the curing agent is incorporated in microspheres to yield a material conformable to the user's foot shape.